ATIP vs. BIAF, BNTC, ZIVO, DMTK, MEIP, CPIX, HLTH, PAVM, ORGS, and NEPH
Should you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include bioAffinity Technologies (BIAF), Benitec Biopharma (BNTC), ZIVO Bioscience (ZIVO), DermTech (DMTK), MEI Pharma (MEIP), Cumberland Pharmaceuticals (CPIX), Cue Health (HLTH), PAVmed (PAVM), Orgenesis (ORGS), and Nephros (NEPH). These companies are all part of the "medical" sector.
bioAffinity Technologies (NASDAQ:BIAF) and ATI Physical Therapy (NYSE:ATIP) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, community ranking, risk, valuation, profitability, institutional ownership and earnings.
In the previous week, bioAffinity Technologies had 2 more articles in the media than ATI Physical Therapy. MarketBeat recorded 3 mentions for bioAffinity Technologies and 1 mentions for ATI Physical Therapy. ATI Physical Therapy's average media sentiment score of -0.32 beat bioAffinity Technologies' score of -1.00 indicating that bioAffinity Technologies is being referred to more favorably in the media.
1.6% of bioAffinity Technologies shares are owned by institutional investors. Comparatively, 72.6% of ATI Physical Therapy shares are owned by institutional investors. 36.4% of bioAffinity Technologies shares are owned by insiders. Comparatively, 0.9% of ATI Physical Therapy shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
bioAffinity Technologies has a beta of 3.15, meaning that its share price is 215% more volatile than the S&P 500. Comparatively, ATI Physical Therapy has a beta of 0.34, meaning that its share price is 66% less volatile than the S&P 500.
ATI Physical Therapy received 15 more outperform votes than bioAffinity Technologies when rated by MarketBeat users.
ATI Physical Therapy has a net margin of -8.15% compared to ATI Physical Therapy's net margin of -171.43%. bioAffinity Technologies' return on equity of 0.00% beat ATI Physical Therapy's return on equity.
bioAffinity Technologies has higher earnings, but lower revenue than ATI Physical Therapy. bioAffinity Technologies is trading at a lower price-to-earnings ratio than ATI Physical Therapy, indicating that it is currently the more affordable of the two stocks.
Summary
bioAffinity Technologies and ATI Physical Therapy tied by winning 7 of the 14 factors compared between the two stocks.
Get ATI Physical Therapy News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ATI Physical Therapy Competitors List
Related Companies and Tools
